However, in hepatocellular tumors, the deletion of BCL9 increased survival rates, reduced liver size and cell proliferation, decreased expression of Wnt target genes, and inhibited the HCC migration and invasion [30, 41, 42]. Here, BCL9 is linked to hepatocellular carcinoma.